Details of Epigenetic Molecule(EM)
| General Information of EM (ID: EM11982) | |||||||
|---|---|---|---|---|---|---|---|
| Official Symbol |
CITED2
|
||||||
| Official Full Name |
Cbp/P300 Interacting Transactivator With Glu/Asp Rich Carboxy-Terminal Domain 2
|
||||||
| Synonym |
Cbp/P300 Interacting Transactivator With Glu/Asp Rich Carboxy-Terminal Domain 2;MRG1;Cbp/P300-Interacting Transactivator 2;MSG-Related Protein 1;MRG-1;Cbp/P300-Interacting Transactivator, With Glu/Asp Rich Carboxy-Terminal Domain, 2;ASD8;VSD2
|
||||||
| Molecule Type |
Protein coding
|
||||||
| Position On Chromosome |
chr6(Start:139371807 - End:139374648)
|
||||||
| Strand |
-
|
||||||
| Uniprot Entry | |||||||
| ENSG ID | |||||||
| Disease Relevance (Click to Show/Hide) | |||||||
| 8A01: Choreiform disorders | Huntington's disease (HD) [Choreiform disorders] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| 8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| LD2C: Overgrowth syndromes | Sotos syndrome(SS) [Overgrowth syndromes] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| XH4XG8: Chronic myeloid leukaemia | Chronic Phase-Chronic Myeloid Leukemia [Chronic myeloid leukaemia] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| XH5QN3: Nephroblastoma | Wilms tumor [Nephroblastoma] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| Metabolite(s) with this epigenetic modification | |||||||
|---|---|---|---|---|---|---|---|
| Metabolite Name: Valerate | |||||||
| Detailed Information |
Meta Info
click to show the detail information of this Metabolite
|
[1], [2] | |||||
| Description |
Valerate has been shown to hypermethylate CITED2 CpG site in breast cancer cells.
|
||||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
